Bio-Techne Corp (NASDAQ:TECH) headquartered in Minneapolis, will host a conference call for the investment community to discuss the 1Q21 earnings result on 5th November 2020 at 9:00 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.bio-techne.com
Earnings Expectation
Bio-Techne Corp is expected to report first quarter earnings results, before market open, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate first quarter income of $ 1.09 per share from revenue of $ 185.03 million. Looking ahead, the full year income are expected at $ 5.44 per share on the revenues of $ 824.22 million.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents.
